Drugmaker Mallinckrodt emerges from bankruptcy
(Reuters) -Drugmaker Mallinckrodt said on Tuesday it has emerged from
drugmaker
Sanofi to explore acquisition of cancer drugmaker Mirati- Bloomberg News
(Reuters) – Paris-based drugmaker Sanofi is exploring a potential acquisition
Drugmaker Mallinckrodt in talks with hedge funds to avoid opioid settlements – WSJ
(Reuters) – Drugmaker Mallinckrodt is talking to hedge funds about
AstraZeneca’s China boss says drugmaker will seek to “love the Communist Party”
By Joe Cash and Brenda Goh BEIJING (Reuters) – Global
Roche buys back shares as family group reduces voting stake in drugmaker
ZURICH (Reuters) – Roche has bought 540,000 of its own
French drugmaker Sanofi expects positive boost from currency markets in Q3
PARIS (Reuters) -French drugmaker Sanofi said it expected a positive
Senate Finance Committee looks at Amgen taxes, widening drugmaker probe
By Michael Erman NEW YORK – The U.S. Senate Finance
Drugmaker Gilead to help fund monkeypox education for LGBTQ+ groups
By Nancy Lapid (Reuters) – Drugmaker Gilead Sciences plans to
Amarin to slash jobs as generic rivals dull U.S. prospects of heart drug
(Reuters) -Amarin Corp Plc said on Monday it would cut
Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement
By Steven Scheer JERUSALEM -Teva Pharmaceutical Industries said on Wednesday